FALCON’s TRILOGY PLATFORM TECHNOLOGY
At the forefront of
personalized cell therapy for solid tumor cancers
Falcon Therapeutics’ proprietary Trilogy Cells hunt, home, and kill hard to reach cancers. We convert a patient’s own skin into tumor-killing machines with lethal precision.
READ MORE
Our Team
Meet our high-powered, experienced team dedicated to improving patient’s lives through groundbreaking science
Susan Nichols
CEO
Shawn Hingtgen
CSO and Founder
Fred Miesowicz
Lead CMC
Joy Cavagnaro
Lead Regulatory
Charlie Turner
VP Business Development
Juliana Blum
Operations Advisor
Kevin Sheets
Lead Product Development
Rhonda Stanley
CFO
Contact Us
Have a question or comment for us? Reach out and we’ll get in touch as soon as we can.